Oncology · Oncology — Benign prostatic hyperplasia
Afaula 5 mg
Cyclophosphamide
Oncology 2–8°C cold chain Cleared
Afaula 5 mg
Cyclophosphamide
Dosage form
Dispersible tablet
Pack size
28 tablets / blister
Manufacturer
Bellarion Generics
SKU
TAB-AFA-0390
CAS #
7915-13-4
ATC code
L0126C
NDC
5386-136-50
Status
approved
Indication
Oncology — Benign prostatic hyperplasia
Compliance
Sourced from licensed manufacturers with full chain-of-custody. WHO-GSDP and EU GDP compliant. Batch records, certificates of analysis and audit documentation supplied on request for institutional orders.
Talk to a pharmacist
A licensed pharmacist will respond within 18 business hours.
Related brands
Same molecule or therapeutic area.
